Six novel mutations in the proopiomelanocortin and melanocortin receptor 4 genes in severely obese adults living in southern Italy

Clinical Chemistry

Volumn 51, Issue 8, 2005, Pages 1358-1364

  Buono, Pasqualina ^a,b,c   Pasanisi, Fabrizio ^b   Nardelli, Carmela ^b   Ieno, Luigi ^b,c   Capone, Silvana ^c   Liguori, Rosario ^b,c   Finelli, Carmine ^b   Oriani, Giovannangelo ^c,d   Contaldo, Franco ^b   Sacchetti, Lucia ^b,c  

^a UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^d UNIVERSITY OF MOLISE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; LIPID; MELANOCORTIN 4 RECEPTOR; PROOPIOMELANOCORTIN;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; EXON; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INSULIN BLOOD LEVEL; ITALY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MELANOCORTIN RECEPTOR 4 GENE; NUCLEOTIDE SEQUENCE; OBESITY; PROOPIOMELANOCORTIN GENE; SEQUENCE ANALYSIS; STOP CODON;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MUTATION; OBESITY; PHENOTYPE; POLYMORPHISM, GENETIC; PRO-OPIOMELANOCORTIN; RECEPTOR, MELANOCORTIN, TYPE 4; SEVERITY OF ILLNESS INDEX;

EID: 23044453212     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.047886     Document Type: Article

References (37)

1. Korner J, Aronne LJ. The emerging science of body weight regulation and its impact on obesity treatment. J Clin Invest 2003;111: 565-70.
2. Marra M, Scalfi L, Contaldo F, Pasanisi F. Fasting respiratory quotient as a predictor of long-term weight changes in non-obese women. Ann Nutr Metab 2004;48:189-92.
3. Schwartz MW, Woods SC, Porte DJ, Seeley RJ, Baskin DG. Central nervous system control of food intake [Review]. Nature 2000;404: 661-71.
4. Coll AP, Farooqi IS, Challis BG, Yeo GS, O'Rahilly S. Proopiomelanocortin and energy balance: insights from human and murine genetics [Review]. J Clin Endocrinol Metab 2004;89:2557-62.
5. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998;19:155-7.
6. Raffin-Sanson ML, de Keyzer Y, Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions [Review]. Eur J Endocrinol 2003;149:79-90.
7. Echwald SM, Sørensen TIA, Andersen T, Tybjaerg-Hansen A, Clausen JO, Pedersen O. Mutational analysis of the proopiomelanocortin gene in Caucasians with early onset obesity. Int J Obes Relat Metab Disord 1999;23:293-8.
8. Challis BG, Pritchard LE, Creemers JWM, Delplanque J, Keogh JM, Luan J, et al. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 2002;11:1997-2004.
9. Miraglia del Giudice E, Cirillo G, Santoro N, D'Urso L, Carbone MT, Di Toro R, et al. Molecular screening of the proopiomelanocortin (POMC) gene in Italian obese children: report of three new mutations. Int J Obes Relat Metab Disord 2001;25:61-7.
10. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994; 8:1298-308.
11. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-41.
12. Miraglia Del Giudice E, Cirillo G, Nigro V, Santoro N, D'Urso L, Raimondo P, et al. Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity. Int J Obes Relat Metab Disord 2002;26:647-51.
13. Santini F, Maffei M, Ceccarini G, Pelosini C, Scartabelli G, Rosellini V, et al. A. Genetic screening for melanocortin-4 receptor mutations in a cohort of Italian obese patients: description and functional characterization of a novel mutation. J Clin Endocrinol Metab 2004;89:904-8.
14. Gu W, Tu Z, Kleyn PW, Kissebah A, Duprat L, Lee J, et al. Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes 1999;48:635-9.
15. Hinney A, Schmidt A, Nottebom K, Heibult O, Becker I, Ziegler A, et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 1999;84:1483-6.
16. Contaldo F, Pasanisi F. Obesity epidemics: secular trend or globalization consequence? Beyond the interaction between genetic and environmental factors. Clin Nutr 2004;23:289-91.
17. Marra M, Pasanisi F, Scalfi L, Colicchio P, Chelucci M, Contaldo F. The prediction of basal metabolic rate in young adult, severely obese patients using single-frequency bioimpedance analysis. Acta Diabetol 2003;40(Suppl):S139-41.
18. den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet 2001;109:121-4.
19. Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW. Improved reagent for enzymatic determination of serum cholesterol. J Clin Chem Biochem 1981;19:838-9.
20. Wahlefeld AW. Triglyceride determination after enzymatic hydrolysis. In: Bergmeyer HU, ed. Methods of enzymatic analysis, 2nd ed., Vol. 4. Weinheim: Verlag Chemie and New York Academic Press, 1974:1831.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
22. Gamier J, Gibrat JF, Robson B. GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol 1996;266:540-53.
23. National Cholesterol Education Program. National Heart, Lung, and Blood Institute. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Publication 02-5215. Bethesda, MD: NIH, 2002:284pp.
24. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003;348:1085-95.
25. Yeo GS, Lank EJ, Farooqi IS, Keogh J, Challis BG, O'Rahilly S. Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum Mol Genet 2003;12:561-74.
26. Yang YK, Harmon CM. Recent developments in our understanding of melanocortin system in the regulation of food intake [Review]. Obesity 2003;4:239-48.
27. Harrold JA, Widdowson PS, Williams G. β-MSH: a functional ligand that regulated energy homeostasis via hypothalamic MC4-R? Peptides 2003;24:397-405.
28. Chatr-aryamontri A, Angelini M, Garelli E, Tchernia G, Ramenghi U, Dianzani I, et al. Nonsense-mediated and nonstop decay of ribosomal protein S19 mRNA in Diamone-Blackfan anemia. Hum Mutat 2004;24:526-33.
29. Robinson SW, Dinulescu DM, Cone RD. Genetic models of obesity and energy balance in the mouse [Review]. Annu Rev Genet 2000;34:687-745.
30. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000;106:253-62.
31. Nijenhuis WAJ, Garner KM, Van Rozen RJ, Adan RAH. Poor cell surface expression of human melanocortin-4 receptor mutations associated with obesity. J Biol Chem 2003;278:22939-45.
32. Hinney A, Hohmann S, Geller F, Vogel C, Hess C, Wermter A-K, et al. Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab 2003;88:4258-67.
33. Srinivasan S, Lubrano-Berthelier C, Govaerts C, Picard F, Santiago P, Conklin BR, et al. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J Clin Invest 2004;114:1158-64.
34. Larsen LH, Echwald SM, Sorensen TI, Andersen T, Wulff BS, Pedersen O. Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J Clin Endocrinol Metab 2005;90:219-24.
35. Lubrano-Berthelier C, Durand E, Dubern B, Shapiro A, Dazin P, Weill J, et al. Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum Mol Genet 2003;12:145-53.
36. VanLeuwen D, Steffey ME, Donahue C, Ho G, MacKenzie RG. Cell surface expression of the melanocortin-4 receptor his dependent on a C-terminal di-isoleucine sequence at codons 316/317. J Biol Chem 2003;278:15935-40.
37. Valli-Jaakola K, Lipsanen-Nyman M, Oksanen L, Hollenberg AN, Kontula K, Bjorbaek C, et al. Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese Finnish children and adults. J Clin Endocrinol Metab 2004;84:940-5.